We expressed the bovine herpesvirus type 1 (BHV-1) glycoproteins, gI and gIII, in bovine cells using a bovine papillomavirus vector. The proteins expressed by these cells had the same Mr as the native BHV-1 proteins and monoclonal antibodies detected no differences in their antigenic structure. Cells expressing gI were infected with either BHV-1 or herpes simplex virus type 1 (HSV-1). The number of plaques in gI-expressing cells was similar to that seen with normal fibroblasts infected with BHV-1 or HSV-1. However, BHV-1 or HSV-1 plaques produced in gI-expressing cells were smaller and darker than those seen in normal fibroblasts indicating an interference with cell-to-cell transmission or cellular lysis. Virus growth curves and [3SS]methionine labelling of BHV-l-infected gI-expressing cells showed no difference in virus production, virus protein synthesis or cellular protein shutdown when compared to BHV-l-infected normal cells. This led us to conclude that the gI protein may interfere with a cellular protein(s) responsible for the cytopathic effects of BHV-1 infection. Cells expressing gIII were fully susceptible to BHV-1 infection.
Short communication
against death from bovine respiratory disease on challenge with a combined infection of BHV-1 and Pasteurella haemolytica (Babiuk et al., 1987) .
We constructed an inducible expression system to produce gI and gIII in bovine cells for use in glycoprotein functional assays and as immunogens. Our system used a bovine papillomavirus type 1 (BPV-1) vector containing the heavy metal-inducible mouse metallothionein (MMT) promoter. In this communication we report the derivation and characterization of these expressed proteins and the effect they have on infection with BHV-1 and HSV-1.
Recombinant DNA plasmids were constructed using standard cloning methods (Maniatis et al., 1982) . The plasmid pBPV-B# 1 was constructed by ligating the gI gene (Zamb, 1987) into p341 (Eiden et al., 1985) between the MMT promoter and the simian virus 40 (SV40) polyadenylation site. This plasmid was ligated to the BPV fragment of BamHI-digested pNeoBPV100 (Lusky & Botchan, 1984) . This ligation resulted in the plasmid pBPV-B# 1 containing the gI gene, the MMT promoter, the SV40 polyadenylation site and the entire genome of BPV (Fig. 1 a) . Plasmid pBPV-C # 1 was constructed by ligating the gIII gene (Zamb, 1987) into p341 (Eiden et al., 1985) . The resultant plasmid, pMC10B, was digested, and the fragment containing the MMT promoter, gIII gene and SV40 polyadenylation site was isolated and ligated into the BamHI site of pCGBPV9AB5 (Matthias et al., 1983) . Plasmid pCGBPVgAB 5 contains the entire genome of BPV-1 and a neomycin phosphotransferase gene providing G418 resistance in eukaryotic cells. Ligation of the gIII gene, MMT promoter and SV40 polyadenylation site into this BPV plasmid resulted in the plasmid pBPV-C # 1 (Fig. 1 b) .
Bovine fibroblasts were used as the eukaryotic host for selection and expression of the recombinant plasmids. Fibroblasts harvested from bovine skin (Freshney, 1983) and grown in MEM (Gibco) containing 5~ foetal calf serum were plated at a density of 2-5 x 10 s cells/25 cm 2 flask. These cells were transfected with 18 gg of pBPV-B # 1 and 2 ~tg of pSV2neo (Southern & Berg, 1982) or 1 pg of pBPV-C # 1 using the calcium phosphate precipitation method (Graham & van der E b, 1973) except that the cells were osmotically shocked with 15 ~ glycerol for 2 min, 3.5 h after the addition of the precipitate. Cells were grown in medium containing 500 lag/ml of active G418 for 2 to 3 weeks. G418-resistant foci of fibroblasts were isolated and cloned using an agarose overlay (Anonymous, 1980) . These resistant clones were screened in an indirect immunofluorescence assay using anti-BHV-1 monoclonal antibodies, 5106 (gI) or 1808 (glII) (Marshall et al., 1986) . Cells expressing gI had fluorescence in the cytoplasm and on the cell membrane (Fig. 2 b) . The intensity of staining was less than in BHV-l-infected cells stained with a gI antibody (Fig. 2a) . Fluorescence in glII-expressing cells was also visible on cell surface membranes and in the cytoplasm (Fig. 2 d) at levels lower than glII-stained BHV-1-infected cells (Fig. 2 c) . Mock-infected cells did not fluoresce after reacting with either the gI or gIII antibodies (results not shown).
In order to compare the characteristics of the recombinant gI to those of the native protein, three gI-expressing cell lines, LB70-B#l, LB70-B#3 and LB64, were labelled with [3SS]methionine, immunoprecipitated, analysed by SDS-PAGE, and visualized by autoradiography (Marshall et al., 1986) . Three proteins with Mr values of 54K, 74K and 130K were present in all three gI-transfected lines (Fig. 3a , lanes 3 to 8) but the LB64 line had faint bands visible only on the original autoradiograph. These proteins had the same Mr as the native gI protein produced by BHV-l-infected bovine fibroblasts (Fig. 3a, lane 2) . The recombinant gI protein from the LB70-B # 3 cell line was immunoprecipitated by monoclonal antibodies against four epitopes suggesting that it had the same immunoreactive domains as the native viral glycoprotein (results not shown). Stimulation with cadmium increased recombinant gI protein production to levels greater than in BHV-l-infected cells (Fig. 3 a, lanes  4 and 6) . Immunoprecipitation of 54K, 74K and 130K proteins from ~2sI surface-labelled LB70-B#3 cells (Markwell & Fox, 1978) confirmed that the recombinant gI protein was being expressed on the cell membrane (results not shown).
To characterize the recombinant gill protein, one gIII-expressing cell line, LBI-d, was surface-labelled with Na ~ 2sI, immunoprecipitated, analysed by SDS-PAGE, and visualized by autoradiography (Marshall et al., 1986) . A protein of 94K to 97K was present in the glIItransfected cells ( immunoprecipitated from BHV-l-infected cells (Fig. 3b, lane 2) . The recombinant protein was immunoprecipitated from the LB l-d cell line by monoclonal antibodies directed against five epitopes suggesting that it had the same immunoreactive domains as the native glII protein (results not shown). Recombinant gill expression was increased in glIItransfected cells by the addition of cadmium chloride (Fig. 3 b, lane 3) . Lysates from bovine fibroblasts containing BPV plasmids alone did not have bands at 54K, 74K or 130K following immunoprecipitation with a gI monoclonal antibody or at 97K following immunoprecipitation with a glII monoclonal antibody (results not shown). Southern blot analysis (Southern, 1975) of LB70-B # 1 and LB70-B # 3 showed the presence of 25 to 50 copies/cell of pBPV-B # 1. The LB 1-d line had only one to five copies/cell of pBPV-C # 1 (results not shown).
The influence of gI expression on transfected cells was also investigated. Exposure of gIexpressing cells for 30 s to media that ranged in pH from 4.8 to 6.35 did not result in polykaryon formation unlike HSV gB-expressing cells that fuse at these pH values (Ali et al., 1987) . Induction of gI expression with 1 I.tM-CdCI2 for 3 to 4 days resulted in cell death but not in polykaryon formation. Normal fibroblasts did not die when treated with the same amount of CdC12 (results not shown).
Viral plaque assays were used to determine the effect of gI and glII expression on BHV-1 infection. Confluent monolayers of normal, gI-expressing (LB70-B#3) or glII-expressing (LBI-d) fibroblasts were infected with 100 p.f.u, of BHV-1, and overlaid with 0-5~ agarose.
On: Thu, 20 Dec 2018 20:27:02 . . . . . glc 6 and 8 ). The 25 cm 2 flasks of cells were incubated for 1 h with methionine-free medium and then labelled for 5 h with 50 ~tCi/ml of [3sS]methionine. The cell lysate was prepared and immunoprecipitations were done as described (Marshall et al., 1986 ) using the 5106 (anti-gI) antibody (b) Autoradiograph of immunoprecipitated glII from cells transfected with pBPV-C # 1. The cells were treated before labelling as described above. The cells were surface-labelled with 200 pCi/ml Na 1251 using a modification of the method previously described (Marshall et al., 1986) . A coverslip coated with 20 ~tg of Iodogen (Pierce Chemicals) was floated on top of a 30 × 15 cm well of confluent cells for 15 min at 25°C. The coverslip was then removed and cell lysate and immunoprecipitates were prepared (Marshall et al., 1986) After 3 days, the monolayers were fixed, stained and the plaques were counted, measured and photographed. There was no difference between the n u m b e r of plaques in B H V -l -i n f e c t e d normal fibroblasts, B H V -l -i n f e c t e d gI-expressing cells or B H V -l -i n f e c t e d glII-expressing cells (Table 1 ). The appearance of BHV-1 plaques in the gI-expressing bovine fibroblasts (Fig. 4 c and  d ) was quite different from the normal bovine fibroblasts (Fig. 4a) or gill-expressing bovine fibroblasts (Fig. 4b) . The gI-expressing fibroblasts had m u c h smaller plaques and m a n y were not clear (Table 1) . T h e glII-expressing fibroblasts had plaques of similar morphology to those seen in normal fibroblasts (Table 1) .
To determine the specificity of the plaque changes, the plaque assay was repeated with 200 p.f.u, of HSV-1 ( M a c l n t i r e strain) in normal, gI-expressing L B 7 0 -B # 1 or L B 7 0 -B # 3 fibroblasts. There was no statistical difference in the number of plaques in the three cell lines either with or without Cd z+ ( Table 2 ). The plaques formed by HSV-1 in gI-expressing cells were smaller and more opaque than those seen in normal fibroblasts ( Table 2 ). The HSV-1 plaques in the gI-expressing cells were larger and more opaque than the BHV-1 plaques (Tables 1 and 2 ). The HSV-1 plaque morphology was very similar to that seen for BHV-1 in Fig. 4 . In order to compare the specificity of this gI effect for herpesvirus infections, normal, gI-or gill-expressing fibroblasts were infected with 1000 p.f.u, of vesicular stomatitis virus. There was no difference in either plaque number or morphology between any of the three groups of cells (results not shown).
To investigate the impact of gI on BHV-1 virus production, 25 cm 2 flasks containing confluent monolayers of normal and gI-expressing fibroblasts were infected with BHV-1 at an m.o.i, of 10. Supernatant and cell lysate from individual flasks were harvested at intervals of 6 h over a 24 h period. Virus titres were determined as described by Rovozzo & Burke (1973) for The influence of gI on viral and cell protein synthesis during infection with BHV-1 was analysed by radiolabelling. Normal and gI-expressing fibroblasts were infected with BHV-1 at an m.o.i, of 10. At 6 h intervals over a 24 h period, the replicate cultures were radiolabelled with 50 p, Ci/ml of [35S]methionine for 5 h and harvested as described by Marshall et al. (1986) . Autoradiographs of this whole cell lysate indicated no difference in the shutdown of cellular proteins nor in viral protein synthesis in normal or gI-expressing cells infected with BHV-1 (results not shown).
Although BPV vectors have been used to express the HSV-1 thymidine kinase gene (Lusky et al., 1983) and other surface proteins such as the envelope glycoprotein of human T cell leukaemia virus (Eiden et al., 1985) , hepatitis B surface protein (Wang et al., 1983) , and the influenza virus haemagglutinin (Sambrook et al., 1985) , this represents the first expression of a herpesvirus glycoprotein gene using a BPV vector. The gI and glII proteins expressed by our transfected bovine cells were indistinguishable from native BHV-1 gI and glII by comparison of Mr and antigenic areas defined by all monoclonal antibodies used to date. Membrane expression of the gI-and glII-transfected proteins was evident from the surface-labelled immunoprecipitation and membrane immunofluorescence.
A useful aspect of this system was the inducibility of gene expression. Maintenance of the cells at a low level of expression was made necessary by the cytopathic effect exerted by higher levels of gI. Addition of the heavy metal ion, cadmium, increased expression of gI and glII to levels near those of infected cells for use in functional studies and for harvesting proteins for use as immunogens.
The function of BHV-1 gI and glII in viral infection has not been established. Our plaque assay indicated that the cellular expression of gI does not inhibit entrance of BHV-1 or HSV-1 into cells as seen by the similar number of plaques in the infected normal and gI-expressing cells. The effect of gI expression on plaques does not appear to involve decreased virus production or release, viral protein synthesis or cellular protein shutdown. However, the gI-expressing fibroblasts had smaller and darker plaques than infected normal fibroblasts. Expression of gI therefore appears to delay lysis and death in cells infected with either BHV-1 or HSV-1. We hypothesize that gI interferes with a cellular protein responsible for fusion or other cytopathic effects to the cell. Interference with a cellular protein necessary for fusion has been hypothesized for another HSV-1 fusion protein, gD (Campadelli-Fiume et al., 1988) . Cell lines expressing glII were fully susceptible to BHV-1 infection as shown by normal plaque size, number and morphology.
The similarity of the HSV gB to BHV-1 gI at an amino acid, antigenic and structural level is very high (Misra et al., 1988 ; Whitbeck et al., 1988) . Therefore the comparable effect on plaque formation seen in HSV-1-and BHV-l-infected gI-expressing cells is not surprising. Although these molecules are closely related, gI does not form polykaryons at low pH in bovine cells
whereas HSV-I gB-expressing simian cells do (Ali et al., 1987) . The fusion function ofgI may be species-specific as the gI gene used in our studies was the same as that used by Fitzpatrick et al., 1988b) when they observed polykaryon formation in gl-expressing murine cells.
The molecular investigation of the biological functions of gI and glII in BHV-1 infection needs to be pursued further. These recombinant proteins could be used to isolate their cellular target proteins in order to further define cell-virus interaction. If these cellular proteins were identified, their role as viral attachment proteins or cell fusion proteins could be assessed.
Since the submission of our manuscript, Conway et al. (1989) have reported on the use of a BPV vector to express gp340/220 of Epstein-Barr virus in murine cells with an MMT promoter. Unlike our system, they did not increase expression of this protein following induction with heavy metals.
